Amphastar Pharmaceuticals (AMPH) Gross Margin: 2013-2025
Historic Gross Margin for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to 51.42%.
- Amphastar Pharmaceuticals' Gross Margin fell 189.00% to 51.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 49.36%, marking a year-over-year decrease of 362.00%. This contributed to the annual value of 51.08% for FY2024, which is 341.00% down from last year.
- According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Gross Margin is 51.42%, which was up 3.69% from 49.59% recorded in Q2 2025.
- Amphastar Pharmaceuticals' 5-year Gross Margin high stood at 60.04% for Q3 2023, and its period low was 43.63% during Q1 2021.
- Over the past 3 years, Amphastar Pharmaceuticals' median Gross Margin value was 52.18% (recorded in 2024), while the average stood at 52.00%.
- In the last 5 years, Amphastar Pharmaceuticals' Gross Margin soared by 1,133bps in 2023 and then crashed by 753bps in 2024.
- Amphastar Pharmaceuticals' Gross Margin (Quarterly) stood at 46.52% in 2021, then spiked by 619bps to 52.71% in 2022, then surged by 127bps to 53.98% in 2023, then slumped by 753bps to 46.45% in 2024, then crashed by 189bps to 51.42% in 2025.
- Its last three reported values are 51.42% in Q3 2025, 49.59% for Q2 2025, and 49.99% during Q1 2025.